PLEXI-T Trademark

Trademark Overview


On Monday, August 19, 2024, a trademark application was filed for PLEXI-T with the United States Patent and Trademark Office. The USPTO has given the PLEXI-T trademark a serial number of 98705565. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Friday, April 4, 2025. This trademark is owned by TScan Therapeutics, Inc.. The PLEXI-T trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Cells for medical or clinical use for use in the treatment of cancer; pharmaceutical and biopharmaceutical preparations for use in the treatment of cancer; T-cell therapy products, namely, T-cell receptor engineered cells for use in the treatment of cancer

Pharmaceutical research and development in the nature of T-cell therapy for the treatment of cancer; T-cell therapy, namely pharmaceutical and scientific research for the treatment of cancer
plexi-t

General Information


Serial Number98705565
Word MarkPLEXI-T
Filing DateMonday, August 19, 2024
Status680 - APPROVED FOR PUBLICATION
Status DateFriday, April 4, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesCells for medical or clinical use for use in the treatment of cancer; pharmaceutical and biopharmaceutical preparations for use in the treatment of cancer; T-cell therapy products, namely, T-cell receptor engineered cells for use in the treatment of cancer
Pseudo MarkPLEXI T
Goods and ServicesPharmaceutical research and development in the nature of T-cell therapy for the treatment of cancer; T-cell therapy, namely pharmaceutical and scientific research for the treatment of cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 19, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, August 19, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTScan Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451

Trademark Events


Event DateEvent Description
Monday, August 19, 2024NEW APPLICATION ENTERED
Saturday, March 8, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, March 9, 2025ASSIGNED TO EXAMINER
Tuesday, April 1, 2025NON-FINAL ACTION E-MAILED
Tuesday, April 1, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 3, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 1, 2025NON-FINAL ACTION WRITTEN
Thursday, April 3, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 3, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 4, 2025APPROVED FOR PUB - PRINCIPAL REGISTER